ASC40

DRUG3 trials

Sponsors

Ascletis Pharmaceuticals Co., Ltd.

Conditions

AcneHealthy

Phase 1

Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects

CompletedNCT04843449

Ascletis Pharmaceuticals Co., Ltd.Healthy

Start: 2021-04-04End: 2021-05-14Updated: 2021-08-23

Phase 3

A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris

CompletedNCT06192264

Ascletis Pharmaceuticals Co., Ltd.Acne

Start: 2024-01-23End: 2025-05-19Updated: 2025-06-19

A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris

CompletedNCT06248008

Ascletis Pharmaceuticals Co., Ltd.Acne

Start: 2024-04-18End: 2025-11-12Updated: 2025-12-01